The recent decline in mortality from coronary heart disease, 1980-1990; The effect of secular trends in risk factors and treatment

JAMA

Volumn 277, Issue 7, 1997, Pages 535-542

  Hunink, Maria G M ^a,c   Goldman, Lee ^a,d   Tosteson, Anna N A ^a,e   Mittleman, Murray A ^b   Goldman, Paula A ^a   Williams, Lawrence W ^a   Tsevat, Joel ^f   Weinstein, Milton C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER MODEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 0031057614     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.7.535     Document Type: Article

References (55)

1. Burke GL, Sprafka JM, Folsom AR, Luepker RV, Norsted SW, Blackburn H. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986: the Minnesota Heart Survey, Int J Epidemiol. 1989;18(suppl I):S73-S81.
2. Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study. N Engl J Med. 1990;322:1635-1641.
3. Jamrozik K, Hockey R. Trends in risk factors for vascular disease in Australia. Med J Aust. 1989; 150:14-18.
4. Sempos C, Cooper R, Kovar MG, McMillen M. Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health. 1988;78:1422-1427.
5. US Dept of Health and Human Services. Detailed diagnoses and procedures, national hospital discharge survey, 1988. Vital Health Stat 13. 1991; No. 107.
6. National Center for Health Statistics. Vital Statistics of the United States, 1988, Volume II: Mortality, Part A. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control; 1991.
7. National Heart, Lung, and Blood Institute. Morbidity From Coronary Heart Disease in the US. Bethesda, Md: National Heart, Lung, and Blood Institute Education Program Information Center; 1990:45. Data Fact Sheet.
8. Elveback LR, Connolly DC, Melton LJ. Coronary heart disease in residents of Rochester, Minnesota, VII: incidence, 1950 through 1982. Mayo Clin Proc. 1986;61:896-900.
9. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-836.
10. Kaplan GA, Cohn BA, Cohen RD, Guralnik J. The decline in ischemic heart disease mortality: prospective evidence from the Alameda County study. Am J Epidemiol. 1988;127:1131-1142.
11. Cohn BA, Kaplan GA, Cohen RD. Did early detection and treatment contribute to the decline in ischemic heart disease mortality? prospective evidence from the Alameda County study. Am J Epidemiol. 1988;127:1143-1154.
12. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the coronary heart disease policy model. Am J Public Health. 1987;77:1417-1426.
13. National Center for Health Statistics. Vital Statistics of the United States 1980, Volume II: Mortality, Part A. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control; 1985.
14. National Center for Health Statistics. Vital Statistics of the United States 1986, Volume II: Mortality, Part A. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control; 1989.
15. Beck JR, Pauker SG. The Markov process in medical prognosis. Med Decis Making. 1983;3:419-458.
16. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-338.
17. Tosteson ANA, Weinstein MC, Williams LW, Goldman L. Long-term impact of smoking cessation on the incidence of coronary heart disease: projections of the coronary heart disease policy model. Am J Public Health. 1990;80:1481-1486.
18. Tsevat J, Weinstein MC, Williams LW, Tosteson ANA, Goldman L. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation. 1991;83:1194-1201.
19. US Bureau of the Census. US Population Estimates by Age, Sex, Race, and Hispanic Origin, 1989: Current Population Reports, Population Estimates and Projections. Washington, DC: US Dept of Commerce, Bureau of the Census; 1990. Series P-25, No. 1057.
20. National Center for Health Statistics. National Health and Nutrition Examination Survey, 1976-1980 [public use data tapes]. Hyattsville, Md: US Dept of Health and Human Services; 1990. Tape Nos. 5305 and 5301 and catalog No. 5411.
21. Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Examination Surveys. JAMA. 1993;269:3002-3008.
22. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205-211.
23. McGovern PG, Burke GL, Sprafka JM, Xue S, Folsom AR, Blackburn H. Trends in mortality, morbidity, and risk factor levels for stroke from 1960 through 1990. JAMA. 1992;268:753-759.
24. National Center for Health Statistics. Vital and Health Statistics: Smoking and Other Tobacco Use, United States, 1987. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service, National Center for Health Statistics; 1989. Series 10, No. 169, PHS 89-1597.
25. National Center for Health Statistics. Current Estimates From the National Health Interview Survey, United States, 1986. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service; 1987. Series 10, No. 164, PHS 87-1592.
26. Gordon DJ, Probstfield JL, Garrison RJ, et al. HDL cholesterol and CVD: four prospective American studies. Circulation. 1989;79:8-15.
27. Gordon DJ. HDL and CHD: an epidemiological perspective. J Drug Dev. 1990;3(suppl 1):11-17.
28. Pocock SJ, Shaper AG, Phillips AN. Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease. BMJ. 1989;298:998-1002.
29. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of MI. N Engl J Med. 1991;325:373-381.
30. Jacobs D, Blackburn H, Higgins M, et al. Report of the conference on low cholesterol: mortality associations. Circulation. 1992;86:1046-1060.
31. US Dept of Health and Human Services, National Institutes of Health. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-Year Follow-up. Bethesda, Md: National Heart, Lung, and Blood Institute, US Dept of Health and Human Services, National Institutes of Health; 1987. Section 34, NIH Publication 87-2703.
32. Longstreth WT, Cobb LA, Fahrenbruch CE, Copass MK. Does age affect outcomes of out-of-hospital cardiopulmonary resuscitation? JAMA. 1990;264:2109-2110.
33. Valenzuela TD, Spaite DW, Meislin HW, Clark LL, Wright AL, Ewy GA, Case and survival definitions in out-of-hospital cardiac arrest. JAMA. 1992; 267:272-274.
34. Wilcox-Gök VL. Survival from out-of-hospital cardiac arrest: a multivariate analysis. Med Care. 1991;29:104-114.
35. Eisenberg MS, Horwood BT, Cummins RO, Reynolds-Haertle R, Hearne TR. Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med. 1990;19:179-186.
36. Eisenberg MS, Cummins RO, Damon S, Larsen MO, Hearne TR. Survival rates from out-of-hospital cardiac arrest: recommendations for uniform definitions and data to report. Ann Emerg Med. 1990;19:1249-1259.
37. Elveback LR, Connolly DC. Coronary heart disease in residents of Rochester, Minnesota, V: prognosis of patients with coronary heart disease based on initial manifestation. Mayo Clin Proc. 1985;60:305-311.
38. US Dept of Health and Human Services. Detailed diagnoses and procedures for patients discharged from short-stay hospitals, National Health Survey, 1986. Vital Health Stat 13. 1988;No. 95.
39. Iezzoni LI, Burnside S, Sickles L, Moskowitz MA, Sawitz E, Levine PA. Coding of acute myocardial infarction. Ann Intern Med. 1988;109:745-751.
40. The Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial. JAMA. 1990;263:1795-1801.
41. National Center for Health Statistics, Centers for Disease Control and Prevention. Cigarette smoking among adults: United States, 1990. MMWR Morb Mortal Wkly Rep. 1992;41:354-362.
42. Fiore MC, Novotny TE, Pierce JP, Hatziandreu EJ, Patel KM, Davis RM. Trends in cigarette smoking in the United States: the changing influence of gender and race. JAMA. 1989;261:49-55.
43. McGovern PG, Folsom AR, Sprafka JM, et al. Trends in survival of hospitalized myocardial infarction patients between 1970 and 1985: the Minnesota Heart Survey. Circulation. 1992;85:172-179.
44. Langa KM, Sussman EJ. The effect of cost-containment policies on rates of coronary revascularization in California. N Engl J Med. 1993;329: 1784-1789.
45. Eisenberg MS, Hallstrom A, Bergner L. Long-term survival after out-of-hospital arrest. N Engl J Med. 1982;306:1340-1343.
46. Schaffer WA, Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of put-of-hospital ventricular fibrillation. N Engl J Med. 1975;293:259-262.
47. Myerburg RJ, Conde CA, Sung RJ, et al. Clinical, electrophysiologic and hemodynamic profile of patients resuscitated from prehospital cardiac arrest. Am J Med. 1980;68:568-575.
48. National Center for Health Statistics. Vital Statistics of the United States 1990, Volume II: Mortality, Part A. Hyattsville, Md: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 1994.
49. US Dept of Health and Human Services. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Vital Health Stat 13. 1992; No. 113.
50. Feinleib M, Havlik RJ, Gillum RF, Pokras R, McCarthy E, Moien M. Coronary heart disease and related procedures: National Hospital Discharge Survey data. Circulation. 1989;79(suppl I):I13-I18.
51. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
52. Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 1991; 265:1145-1151.
53. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
54. McGovern PG, Pankow JS, Shahar E, et al, for the Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease: mortality, morbidity, medical care, and risk factors. N Engl J Med. 1996;334:884-890.
55. Bonneux L, Barendregt JJ, Meeter K, Bonsel GJ, van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health. 1994;84:20-28.